tirzepatide and menopause New research from a Mayo Clinic–led study suggests that postmenopausal women using hormone therapy may experience greater weight loss when treated with tirzepatide, a GLP-1–based medication for overweight obesity. In Is Microdosing Tirzepatide Safe? vs.

It argues this matters for GLP-1 users specifically because reduced appetite and lower fluid intake already leave less margin, raising the risk of dehydration and protein deficiency after donating

Why GLP-1 Medications Are a Powerful Investment in Your Health At Balanced Vitality Center, we dont just hand over a prescriptionwe provide personalized, expert-guided care to make sure the medication is right for you and used safely and effectively

"We're not sure why, but it does tend to get better with time," Corrado says

Presented for research literature review only Papanikolaou T et al

Benefits The product promotes an even skin tone and gives you a natural glow